loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 2470268 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 COAGULATION FACTOR IX (RECOMBINANT), PEGYLATED (1)

filter

01 NOVO NORDISK CANADA INC (1)

filter

01 POWDER FOR SOLUTION (1)

filter

01 1000UNIT/VIAL (1)

filter

01 Canada (1)

URL Supplier Web Content
POWDER FOR SOLUTION
1000UNIT/VIAL
REBINYN
Canada
2470268
1000 IU VIAL
Schedule D
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2470268

Looking for CTD TGA MCC DOSSIER APPLICATION 2470268 1

19

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is COAGULATION FACTOR IX (RECOMBINANT), PEGYLATED, with a corresponding application number 2470268 and regulatory information .

proudly manufactured in the

Novo Nordisk's REBINYN POWDER FOR SOLUTION, medication with 1000UNIT/VIAL of COAGULATION FACTOR IX (RECOMBINANT), PEGYLATED.

Post Enquiry
POST ENQUIRY